Randomised trials in ovarian cancer: trial design considerations

Citation
Mf. Brady et al., Randomised trials in ovarian cancer: trial design considerations, ANN ONCOL, 10, 1999, pp. 75-82
Citations number
29
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
ANNALS OF ONCOLOGY
ISSN journal
09237534 → ACNP
Volume
10
Year of publication
1999
Supplement
1
Pages
75 - 82
Database
ISI
SICI code
0923-7534(1999)10:<75:RTIOCT>2.0.ZU;2-Y
Abstract
Randomised clinical trials are considered the definitive source of evidence for guiding decisions in clinical practice. The concept of a clinical tria l is based on sound scientific, ethical, and practical principles. The stre ngth of evidence that an individual trial provides is assessed on the manne r in which these principles are incorporated into the design and execution of the trial. Since the way these principles are incorporated into a trial is judgmental, the strength of evidence from an individual trial is a matte r of degree. The purpose of this paper is to present some of the scientific , ethical and practical considerations surrounding the selection of endpoin ts and determination of sample size for trials in ovarian cancer.